Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

FRESH TRACKS THERAPEUTICS (FRTX)

No description provided.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/01/1970

Market Cap

5,674,645

Shares Outstanding

N/A

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

Beta

0.4800

Last Div

0.0000

Range

0.56-1.04

Chg

0.0700

Avg Vol

14987

Mkt Cap

5674645

Exch

NASDAQ

Country

Phone

720 505 4755

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

0.7088

EV Multiple

0.8991

P/FV

0.5657

Div Yield %

0.0000

P/E

-0.9974

PEG

-0.0115

Payout

0.0000

Current Ratio

6.9758

Quick Ratio

6.6467

Cash Ratio

6.5628

DSO

2.0516

DIO

78.1631

Op Cycle

80.2147

DPO

58.2279

CCC

21.9868

Gross Margin

0.6821

Op Margin

-0.7944

Pretax Margin

-0.7358

Net Margin

-0.7035

Eff Tax Rate

-0.0721

ROA

-0.4861

ROE

-0.5816

ROCE

-0.6405

NI/EBT

0.9560

EBT/EBIT

0.9263

EBIT/Rev

-0.7944

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-1272.0000

CF/Debt

0.0000

Equity Multi

1.1668

Rec Turnover

177.9111

Pay Turnover

6.2685

Inv Turnover

4.6697

FA Turnover

235.4706

Asset Turnover

0.6910

OCF/Share

-0.7345

FCF/Share

-0.7345

Cash/Share

1.8381

OCF/Sales

-0.5425

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.5657

P/B

0.5657

P/S

0.7088

P/E

-0.9974

P/FCF

-1.3066

P/OCF

-1.2934

P/CF

-1.2934

PEG

-0.0115

P/S

0.7088

EV Multiple

0.8991

P/FV

0.5657

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 19, 17:18 Fresh Tracks Therapeutics Announces Listing on OTC Pink Market FRTX, FRTX GlobeNewswire Inc. Dec 01, 17:00 Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders FRTX GlobeNewswire Inc. Nov 17, 08:30 Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders FRTX GlobeNewswire Inc. Nov 13, 08:30 Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update FRTX

Revenue Product Segmentation

Year	Purchases	Sales	Total Bought	Total Sold

Transaction Date	Name	Type Of Owner	Price	Securities Owned	Securities Transacted	Security Name	Transaction Type

Less Than 3 Months

775.27K Shares Bought (100.00 %)

0.00 Shares Sold (0.00%)

3 - 6 Months

264.14K Shares Bought (96.62 %)

9.25K Shares Sold (3.38%)

6 - 9 Months

122.00K Shares Bought (47.79 %)

133.30K Shares Sold (52.21%)

9 - 12 Months

35.00K Shares Bought (41.19 %)

49.98K Shares Sold (58.81 %)

Investor Name	Investment Discretion	Type of Security	Shares Owned	Avg Price Paid	Market Value	Change In Market Value	Change In Market Value (%)	Ownership	Weight

Date	Investors Holding	Closed Positions	Increased Positions	Reduced Positions	New Positions	Total Invested	Put/Call Ratio	Total Calls	Total Puts

Owner	Shares Owned

	2018	2019	2020	2021	2022	2023	2023
Revenue	3.95M	▼ 124.00K	▲ 669.00K	▼ 27.00K	▲ 104.00K	▲ 2.05M	▼ 0.00
Cost Of Revenue	1.79M	▼ 0.00	0.00	0.00	0.00	▲ 2.61M	▼ 0.00
Gross Profit	2.16M	▼ 124.00K	▲ 669.00K	▼ 27.00K	▲ 104.00K	▼ -555.00K	▲ 0.00
Gross Profit Ratio	0.55	▲ 1.00	1.00	1.00	1.00	▼ -0.27	▲ 0.00
Research And Development Expenses	4.45M	▼ 2.56M	▲ 6.63M	▼ 4.56M	▼ 3.12M	▼ 2.61M	▼ 10.00K
General And Administrative Expenses	3.39M	▼ 1.52M	▲ 4.88M	▼ 2.87M	▲ 3.29M	▲ 4.04M	▼ 1.64M
Selling And Marketing Expenses	1.79M	▼ 0.00	0.00	0.00	0.00	0.00	0.00
Selling General And Administrative Expenses	3.39M	▼ 1.52M	▲ 4.88M	▼ 2.87M	▲ 3.29M	▲ 4.04M	▼ 1.64M
Other Expenses	-1.79M	▲ 0.00	0.00	0.00	0.00	▲ 69.00K	▲ 414.00K
Operating Expenses	7.83M	▼ 4.08M	▲ 11.51M	▼ 7.43M	▼ 6.41M	▲ 6.64M	▼ 1.65M
Cost And Expenses	7.83M	▼ 4.08M	▲ 11.51M	▼ 7.43M	▼ 6.41M	▲ 6.64M	▼ 1.65M
Interest Income	0.00	0.00	0.00	0.00	0.00	▲ 3.00K	▼ 0.00
Interest Expense	0.00	0.00	▲ 114.00K	▼ 0.00	▲ 4.00K	▼ 3.00K	▼ 0.00
Depreciation And Amortization	71.00K	▼ 16.00K	▼ -47.00K	▲ 1.00K	▲ 7.00K	▲ 69.00K	▼ 10.00K
Ebitda	-4.03M	▼ -4.30M	▼ -10.84M	▲ -7.40M	▲ -6.31M	▲ -4.52M	▲ -1.23M
Ebitda Ratio	-1.02	▼ -34.65	▲ -16.20	▼ -100.00	▲ -60.63	▲ -2.21	▲ 0.00
Operating Income	-3.88M	▼ -3.95M	▼ -10.84M	▲ -7.40M	▲ -6.31M	▲ -4.59M	▲ -1.65M
Operating Income Ratio	-0.98	▼ -31.86	▲ -16.20	▼ -274.11	▲ -60.63	▲ -2.24	▲ 0.00
Total Other Income Expenses Net	153.00K	▲ 346.00K	▼ 93.00K	▼ 36.00K	▲ 242.00K	▼ 66.00K	▲ 414.00K
Income Before Tax	-3.73M	▲ -3.61M	▼ -10.86M	▲ -7.37M	▲ -6.07M	▲ -4.53M	▲ -1.24M
Income Before Tax Ratio	-0.94	▼ -29.07	▲ -16.24	▼ -100.00	▲ -58.34	▲ -2.21	▲ 0.00
Income Tax Expense	-224.00K	▼ -362.00K	▲ 161.00K	▼ -1.00K	▲ 4.00K	▼ -383.00K	▲ 414.00K
Net Income	-3.73M	▲ -3.61M	▼ -10.86M	▲ -7.37M	▲ -6.07M	▲ -4.14M	▲ -1.24M
Net Income Ratio	-0.94	▼ -29.07	▲ -16.24	▼ -100.00	▲ -58.34	▲ -2.02	▲ 0.00
Eps	-66.05	▲ -51.99	▼ -61.94	▲ -6.84	▲ -2.53	▲ -1.38	▲ -0.21
Eps Diluted	-66.05	▲ -51.99	▼ -61.94	▲ -6.84	▲ -2.53	▲ -1.38	▲ -0.21
Weighted Average Shs Out	56.44K	▲ 69.35K	▲ 175.35K	▲ 1.08M	▲ 2.40M	▲ 3.01M	▲ 5.91M
Weighted Average Shs Out Dil	56.44K	▲ 69.35K	▲ 175.35K	▲ 1.08M	▲ 2.40M	▲ 3.01M	▲ 5.91M
Link	View	View	View	View	View	View	View
Final Link	View	View	View	View	View	View	View

	2018	2019	2020	2021	2022	2023	2023
Cash And Cash Equivalents	24.84M	▼ 8.07M	▼ 7.23M	▲ 30.12M	▼ 26.88M	▼ 8.68M	▲ 10.87M
Short Term Investments	35.66M	▲ 36.20M	▼ 4.50M	▼ 0.00	0.00	0.00	0.00
Cash And Short Term Investments	60.69M	▼ 48.07M	▼ 7.23M	▲ 30.12M	▼ 26.88M	▼ 8.68M	▲ 10.87M
Net Receivables	5.12M	▼ 1.13M	▼ 0.00	0.00	0.00	▲ 504.00K	▼ 45.00K
Inventory	-5.12M	▲ -1.13M	▲ 0.00	0.00	0.00	▼ -504.00K	▲ 545.00K
Other Current Assets	15.63M	▼ 1.13M	▲ 6.24M	▼ 3.42M	▼ 2.72M	▼ 1.40M	▼ 94.00K
Total Current Assets	76.32M	▼ 49.20M	▼ 17.97M	▲ 33.53M	▼ 29.60M	▼ 10.08M	▲ 11.55M
Property Plant Equipment Net	606.00K	▼ 100.00K	▲ 175.00K	▼ 104.00K	▲ 117.00K	▲ 124.00K	▼ 34.00K
Goodwill	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	703.00K	▼ 0.00	0.00	0.00	0.00	▲ 1.47M	▼ 0.00
Goodwill And Intangible Assets	703.00K	▼ 441.00K	▼ 0.00	0.00	0.00	▲ 1.47M	▼ 0.00
Long Term Investments	2.21M	▲ 2.39M	▼ 0.00	0.00	0.00	0.00	0.00
Tax Assets	-703.00K	▲ -441.00K	▲ 0.00	0.00	0.00	0.00	0.00
Other Non Current Assets	1.36M	▼ 659.00K	▼ 0.00	0.00	0.00	▼ -1.41M	▲ 0.00
Total Non Current Assets	4.18M	▼ 3.15M	▼ 175.00K	▼ 104.00K	▲ 117.00K	▲ 188.00K	▼ 34.00K
Other Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	80.49M	▼ 52.34M	▼ 18.14M	▲ 33.63M	▼ 29.72M	▼ 10.27M	▲ 11.59M
Account Payables	1.21M	▲ 4.07M	▼ 2.25M	▼ 568.00K	▲ 1.61M	▼ 571.00K	▼ 406.00K
Short Term Debt	0.00	▲ 4.64M	▼ 78.00K	▲ 365.00K	▼ 69.00K	▼ 49.00K	▼ 0.00
Tax Payables	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Revenue	11.70M	▼ 8.12M	▼ 1.80M	▼ 0.00	0.00	0.00	0.00
Other Current Liabilities	4.00M	▼ -13.24M	▲ 6.38M	▼ 5.42M	▼ 3.14M	▼ 2.46M	▼ 1.25M
Total Current Liabilities	16.92M	▼ 3.58M	▲ 10.50M	▼ 6.35M	▼ 4.81M	▼ 3.08M	▼ 1.66M
Long Term Debt	0.00	0.00	▲ 73.00K	▲ 146.00K	▼ 0.00	0.00	0.00
Deferred Revenue Non Current	0.00	▲ 1.60M	▼ 0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities Non Current	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non Current Liabilities	0.00	▼ -1.60M	▲ 0.00	0.00	▲ 1.67M	▼ 620.00K	▼ 0.00
Total Non Current Liabilities	0.00	▲ 1.74M	▼ 73.00K	▲ 146.00K	▲ 1.67M	▼ 620.00K	▼ 0.00
Other Liabilities	0.00	▼ -1.74M	▲ 0.00	0.00	▼ -1.67M	▲ -620.00K	▲ 0.00
Capital Lease Obligations	0.00	0.00	▲ 151.00K	▼ 74.00K	▼ 69.00K	▼ 49.00K	▼ 0.00
Total Liabilities	16.92M	▼ 3.58M	▲ 10.57M	▼ 6.50M	▼ 4.81M	▼ 3.08M	▼ 1.66M
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Common Stock	218.00K	218.00K	▼ 85.00K	▲ 536.00K	▲ 1.19M	▼ 30.00K	▲ 60.00K
Retained Earnings	-426.74M	▲ -71.62M	▼ -84.98M	▼ -105.89M	▼ -145.37M	▼ -166.47M	▼ -172.16M
Accumulated Other Comprehensive Income Loss	122.00K	▲ 272.00K	▼ -28.00K	▲ 0.00	0.00	0.00	0.00
Other Total Stockholders Equity	489.98M	▲ 490.34M	▼ 92.50M	▲ 132.49M	▲ 169.08M	▲ 173.63M	▲ 182.03M
Total Stockholders Equity	63.58M	▼ 48.76M	▼ 7.57M	▲ 27.14M	▼ 24.91M	▼ 7.19M	▲ 9.93M
Total Equity	63.58M	▼ 48.76M	▼ 7.57M	▲ 27.14M	▼ 24.91M	▼ 7.19M	▲ 9.93M
Total Liabilities And Stockholders Equity	80.49M	▼ 52.34M	▼ 18.14M	▲ 33.63M	▼ 29.72M	▼ 10.27M	▲ 11.59M
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities And Total Equity	80.49M	▼ 52.34M	▼ 18.14M	▲ 33.63M	▼ 29.72M	▼ 10.27M	▲ 11.59M
Total Investments	37.87M	▲ 38.59M	▼ 4.50M	▼ 0.00	0.00	0.00	0.00
Total Debt	0.00	▲ 4.64M	▼ 151.00K	▲ 511.00K	▼ 69.00K	▼ 49.00K	▼ 0.00
Net Debt	-24.84M	▲ -3.43M	▼ -7.08M	▼ -29.60M	▲ -26.82M	▲ -8.63M	▼ -10.87M
Link	View	View	View	View	View	View	View
Final Link	View	View	View	View	View	View	View

	2018	2019	2020	2021	2022	2023	2023
Net Income	-3.73M	▲ -3.61M	▼ -10.86M	▲ -7.37M	▲ -6.07M	▲ -4.53M	▲ -1.24M
Depreciation And Amortization	71.00K	▼ 16.00K	▼ -47.00K	▲ 1.00K	▲ 7.00K	▲ 9.00K	▲ 10.00K
Deferred Income Tax	0.00	0.00	▲ 425.00K	▼ 0.00	0.00	▲ 132.07M	▼ 0.00
Stock Based Compensation	145.00K	▼ 93.00K	▲ 525.00K	▲ 584.00K	▲ 596.00K	▼ 490.00K	▼ 267.00K
Change In Working Capital	1.82M	▼ 1.02M	▼ -4.47M	▲ 1.53M	▼ 603.00K	▲ 1.44M	▼ -163.00K
Accounts Receivables	-2.29M	▲ 974.00K	▼ 0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payables	0.00	0.00	▲ 954.00K	▼ -558.00K	▲ 267.00K	▼ -873.00K	▲ -203.00K
Other Working Capital	4.11M	▼ 49.00K	▼ -5.42M	▲ 2.09M	▼ 336.00K	▲ 2.31M	▼ 40.00K
Other Non Cash Items	0.00	▼ -105.00K	▲ 387.00K	▲ 500.00K	▼ 63.00K	▼ -132.05M	▲ 0.00
Net Cash Provided By Operating Activities	-1.70M	▼ -2.58M	▼ -14.04M	▲ -4.75M	▼ -4.80M	▲ -2.58M	▲ -1.12M
Investments In Property Plant And Equipment	-53.00K	▲ -1.00K	▲ 0.00	0.00	0.00	▲ 47.00K	▼ 0.00
Acquisitions Net	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Purchases Of Investments	-24.47M	▲ -14.31M	▲ 0.00	0.00	0.00	0.00	0.00
Sales Maturities Of Investments	11.41M	▲ 16.46M	▼ 14.00M	▼ 0.00	0.00	0.00	0.00
Other Investing Activities	0.00	0.00	▲ 1.00K	▼ -23.00K	▲ 0.00	0.00	0.00
Net Cash Used For Investing Activities	-13.11M	▲ 2.16M	▲ 14.00M	▼ -23.00K	▲ 0.00	▲ 47.00K	▼ 0.00
Debt Repayment	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Common Stock Issued	29.43M	▼ 0.00	0.00	▲ 14.71M	▼ 10.32M	▼ 131.00K	▼ 0.00
Common Stock Repurchased	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividends Paid	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	-1.00K	▲ 0.00	▲ 47.00K	▼ 3.00K	▼ -22.00K	▼ -123.00K	▲ -28.00K
Net Cash Used Provided By Financing Activities	29.43M	▼ 0.00	▲ 47.00K	▲ 14.72M	▼ 10.30M	▼ 8.00K	▼ -28.00K
Effect Of Forex Changes On Cash	0.00	0.00	0.00	0.00	0.00	▼ -47.00K	▲ 0.00
Net Change In Cash	14.63M	▼ -423.00K	▲ 7.00K	▲ 9.94M	▼ 5.50M	▼ -2.57M	▲ -1.15M
Cash At End Of Period	25.03M	▼ 11.87M	▼ 7.23M	▲ 30.12M	▼ 26.88M	▼ 8.68M	▲ 10.87M
Cash At Beginning Of Period	10.40M	▲ 12.29M	▼ 7.23M	▲ 20.17M	▲ 21.38M	▼ 11.25M	▲ 12.02M
Operating Cash Flow	-1.70M	▼ -2.58M	▼ -14.04M	▲ -4.75M	▼ -4.80M	▲ -2.58M	▲ -1.12M
Capital Expenditure	-53.00K	▲ -1.00K	▲ 0.00	0.00	0.00	▲ 47.00K	▼ 0.00
Free Cash Flow	-1.75M	▼ -2.58M	▼ -14.04M	▲ -4.75M	▼ -4.80M	▲ -2.53M	▲ -1.12M
Link	View	View	View	View	View	View	View
Final Link	View	View	View	View	View	View	View